Dallas Startup to Develop Genome Scanning Tool for Vaccine Discovery | GenomeWeb

NEW YORK, Feb 8 – Eliance Biotechnology of Dallas has gained exclusive rights to develop large-scale genetic screening technology from the Center for Biomedical Inventions at University of Texas Southwestern Medical Center, the university announced Thursday.

The technology, called Expression Library Immunization, is designed to screen bacterial and viral genomes for vaccines and other agents with potential immunological value.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.